Paran Yael, Yablecovitch Doron, Choshen Guy, Zeitlin Ina, Rogowski Ori, Ben-Ami Ronen, Katzir Michal, Saranga Hila, Rosenzweig Tovit, Justo Dan, Orbach Yaffa, Halpern Pinhas, Berliner Shlomo
Department of Internal Medicine D, E and H, Tel-Aviv Sourasky Medical Center, 6 Weitzman Street, Tel-Aviv 64239, Israel.
Crit Care. 2009;13(2):R50. doi: 10.1186/cc7775. Epub 2009 Apr 8.
C-reactive protein (CRP) is a real-time and low-cost biomarker to distinguish febrile bacterial infections from non-bacterial febrile illnesses. We hypothesised that measuring the velocity of the biomarker instead of its absolute serum concentration could enhance its ability to differentiate between these two conditions.
We prospectively recruited adult patients (age >or= 18 years) who presented to the emergency department with fever. We recorded their data regarding the onset of fever and accompanying symptoms. CRP measurements were obtained upon admission. CRP velocity (CRPv) was defined as the ratio between CRP on admission and the number of hours since the onset of fever. Patients were diagnosed by clinical symptoms, blood cultures and imaging studies, and the diagnoses were confirmed by an infectious disease specialist. The efficacy of CRPv as a diagnostic marker was evaluated by using receiver operator curves (ROC). Excluded were patients who did not know the time fever started with certainty, patients with malignancy, patients with HIV infection and patients who had been using antibiotics upon presentation.
Of 178 eligible patients, 108 (60.7%) had febrile bacterial infections (mean CRP: 63.77 mg/L, mean CRPv: 3.61 mg/L/hour) and 70 (39.3%) had non-bacterial febrile illnesses (mean CRP: 23.2 mg/L, mean CRPv: 0.41 mg/L/hour). The area under the curve for CRP and CRPv were 0.783 (95% confidence interval (CI) = 0.717 to 0.850) and 0.871 (95% CI = 0.817 to 0.924), respectively. In a 122-patient subgroup with a CRP level of less than 100 mg/L, the area under the curve increased from 0.689 (95% CI = 0.0595 to 0.782) to 0.842 (95% CI = 0.77 to 0.914) by using the CRPv measurements.
CRPv improved differentiation between febrile bacterial infections and non-bacterial febrile illnesses compared with CRP alone, and could identify individuals who need prompt therapeutic intervention.
C反应蛋白(CRP)是一种用于区分发热性细菌感染和非细菌性发热疾病的实时且低成本的生物标志物。我们假设,测量生物标志物的变化速度而非其血清绝对浓度,可能会增强其区分这两种情况的能力。
我们前瞻性招募了因发热前往急诊科就诊的成年患者(年龄≥18岁)。我们记录了他们发热起始时间及伴随症状的数据。入院时进行CRP检测。CRP变化速度(CRPv)定义为入院时的CRP与发热起始后小时数的比值。患者通过临床症状、血培养及影像学检查进行诊断,诊断由感染病专科医生确认。使用受试者工作特征曲线(ROC)评估CRPv作为诊断标志物的效能。排除那些无法确切知晓发热起始时间的患者、恶性肿瘤患者、HIV感染患者以及就诊时正在使用抗生素的患者。
178例符合条件的患者中,108例(60.7%)患有发热性细菌感染(平均CRP:63.77mg/L,平均CRPv:3.61mg/L/小时),70例(39.3%)患有非细菌性发热疾病(平均CRP:23.2mg/L,平均CRPv:0.41mg/L/小时)。CRP和CRPv的曲线下面积分别为0.783(95%置信区间(CI)=0.717至0.850)和0.871(95%CI = 0.817至0.924)。在CRP水平低于100mg/L的122例患者亚组中,通过使用CRPv测量,曲线下面积从0.689(95%CI = 0.595至0.782)增至0.842(95%CI = 0.77至0.914)。
与单独使用CRP相比,CRPv改善了发热性细菌感染和非细菌性发热疾病之间的鉴别能力,并且能够识别需要及时进行治疗干预的个体。